Arimidex question - American Cancer Society

Hi everyone... It's been awhile since I have been on here. I hate that I forget to pull this site up and look at it more often. Lately have felt the need for support more now that when I was diagnosed last year. At any rate - I started Arimidex in January ...

CT Scan Results *UPDATE* - American Cancer Society

The radiologist could not make a determination and cannot rule out cancer. ( an afterthought .... I am taking Arimidex. Wouldn't that mean the nodules are not from breast cancer?) So I am breathing and holding my breath a little bit too. A new scan is ...

Recent Performance Review For 6 Large-Cap Drug Makers Yielding Over 4% - Seekingalpha.com

The firm has sought out acquisitions to offset patent losses, including the forthcoming expirations of Seroquel and Arimidex. See a recent performance chart for AZN: (Click to enlarge) The best performing listed equity over the last year was LLY ...

Global endocrinology market is set to show moderate growth in near future - Transworld News

The expected growth in the endocrinology market in the forecast period will be contributed by the expected launches of few promising molecules such as PLB03002, Arimidex, Pasireotide and C2L. Arimidex is a novel drug whereas PLB03002 is an improved ...

Increased Mammograms Up to 65% Responsible for Breast Cancer Mortality Reduction - msnbc.com

Drugs covered include: Abiraterone acetate (Zytiga), Afatinib (Tomtovok), Afimoxifene (TamoGel), Albumin-bound paclitaxel (Abraxane), Anastrozole (Arimidex), Apatinib, Bevacizumab (Avastin), Bosutinib, Capecitabine (Xeloda), Cediranib ...

Mammary carcinoma: estrogen levels following menopause may impact risk of joint pain caused by aromatase inhibitors - Xagena Medical News

Patients in the new study were taking aromatase inhibitors including Arimidex ( Anastrozole ) , Femara ( Letrozole ) or Aromasin ( Exemestane ). Of the 300 patients enrolled in the study, 139 reported aromatase inhibitor-related pain, with 75 percent of ...